Enhance Knowledge | EnhKnowTM , LLC
Technology Brokerage & Royalty Servicing

 
 

 

 

Not Available Yet

Company Facility Photo

 BioSynthesis Sequencing Laboratory
A Managed Adopter Venture of EnhKnow LLC

 
Summary Company Profile
State of Formation: Ireland (proposed)
Year of Formation: 2022 (proposed)

Residency (HQ): Ireland (proposed)
Year of Inception: 2022 (proposed -follow us)

Brokerage Participation: Open
Participation Program:
By Invitation Only
Investment Fund
: CCECT-PT Capital Investment Fund (proposed)
Investment Fund Manager
: N/A
Investment Documents Printing
: Okumaye Publishing Co, Inc
Investment Contact
: Opubo G Benebo (opubob@enhknow.com)

Venture Background:
Website: http://biotechdata.enhknow (not active as yet)
Company Business:

Implementation and performing of computational algorithms for BioTech Industries for predictive analytics of Clinical Trials, Medications Bioactivity, Drug Design Bioactivity and Cell Culture Sterilization Dynamics.
Company Industry:
Biotechnology industries with special focus on the Biomedical, BioPharmaceuticals, and Fermentation Industries
Production Technology:
Base Technology: Adoption Software:
Biotech Data Analytics; Biotech Computing Systems;         
          Bioinformatics Computing 
Management Contact: Opubo G Benebo,
                                      Executive Chairman,
                                      email: opubob@enhknow.com

          

About Venture:
A special biotechnology computational research company, the Biosynthesis Sequencer Laboratory (the name may change) performs computation-intensive mechanism and kinetics analysis of biologics synthesis reactions for biological sciences researchers interested in bio-reactions dynamics analyses.

Such analyses are particularly useful in the computational analysis of the growth and remission dynamics of cancer cells, in understanding the replication of virus as well as teasing out the accuracy of experimental studies of epidemiology, immunology and virology, and generally in the ignition o diseases in cells

Biosynthesis Sequencer Laboratory is a Managed Adopter Venture being developed on the demand of the Pool Brokerage Division as part of its role as surrogate adopter for the listed prospected beneficiaries of the computed data. Even while still in founding the laboratory is set to provide such support to Qualprean, Inc in its computational prognostic oncology research.

 

Market Participation Planning
Products:
 Diseases Growth Biosynthesis Kinetics
 Virus Duplication Reactions Mechanisms
 Microbes Acculturation Reactions Kinetics
 Toxicity Bioreactions and Kinetics
 Drug Efficacy Bio-Reaction Kinetics
Active Computational Research  Topics
Virus Replication Computations...
Corona Virus Infection Spread
Corona Virus In-cell Replication Rates
mRNA Vaccines Immunity-generating Assessment
Corona Virus Infection Natural-Immunity-generating Mechanism
Diseases Prognostics Data...
Bioreactions Ignition Analysis
Drug Efficacy Data...
Diseases Treatment Drugs Metabolism
Drug-driven Corona Virus mRNA Deactivation
Notable Ongoing Computational Research
March 2020
Coronavirus Replication:
Biosynthesis Sequence Computations is  based on the Corona virus Replication Science Frameworks

 

 

 

 

   

Company

 Company 
 
About Us
 
News and Events
 
Contact Us

Governance

 Board of Directors
 Memberships

Publications

 Media & Press-Releases
 Whitepapers

 Business Articles

Technology Matters

 Technology Validation
 Technology Licensing
 Technology Analysis

 

 

Legal

 Privacy Policy
 
Term of Use
 
site map

 Copyright

Knowledge-Advance

 Announcements
 Broker Training
 Seminars
 Conferences
 Technology Shows

 Research Reports

Participation Terms

Seminar Registration
Conferences Registration
Symposia Registrations
Tech-Shows Registrations

 
copyright © 2008 - , Enhance Knowledge LLC, All rights Reserved